By Femtech Insider Biotech, Gynecological Health, News, Pelvic Health, Pharma, Uncategorized, Women's Health June 1, 2021 ShareTwitterFacebookPinterest-circled Myovant and Pfizer Receive FDA Approval for MYFEMBREE, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids
By Femtech Insider Biotech, Career, News, Pharma, Uncategorized May 31, 2021 ShareTwitterFacebookPinterest-circled Dr. Stephen Palmer Joins the Celmatix Executive Team to Lead the Company’s Drug Discovery and Development Efforts in Ovarian Health as Chief Scientific Officer
By Femtech Insider Investment, News, Reproductive Health, Uncategorized May 28, 2021 ShareTwitterFacebookPinterest-circled Madrid-based IVF Startup Overture Life Raises a $15M Series B
By Femtech Insider Access, Ecosystem, Menstrual Health, News, Uncategorized May 25, 2021 ShareTwitterFacebookPinterest-circled Always Participates in a U.S. Congressional Event and Releases New Global Data to Break Period Stigma
By Femtech Insider Investment, News, Uncategorized May 24, 2021 ShareTwitterFacebookPinterest-circled CBD Therapeutics Startup Prima Raises a $9.2M Seed Plus Round
By Femtech Insider News, Oncology, Pelvic Health, Uncategorized, Women's Health May 13, 2021 ShareTwitterFacebookPinterest-circled Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health
By Femtech Insider Access, News, Reproductive Health, Uncategorized May 12, 2021 ShareTwitterFacebookPinterest-circled Twentyeight Health Announces U.S. Expansion to Increase Birth Control Access for Underserved Communities